AUX-202

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAUX-202
Drug Alias Namebone metastases therapy (Auxeris)AUX-201AUX-202.2AUX-202.1AUX-202.3 +[6] 
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitorsOsteoclast modulators
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAuxeris Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAuxeris Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsBone metastases

Other Information

ATC CodeN/A
Related LinksN/A